. . . . . . . . . . . . . "p(HGNC:MAPK8) -> bp(MESHPP:\"Insulin Resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Finally, removal of inflammatory mediators or pathway components, such as TNF-?, JNK, and IKK, protects against insulin resistance in obese mouse models, and treatment of humans with drugs that target these pathways, such as salicylates, improves insulin sensitivity" . . "Selventa" . . . . "2014-07-03T14:30:35.011+02:00"^^ . . .